SCHEMBL363064

SCHEMBL363064

CCCCC(CC)COC(=O)/C=C(/C)C(=O)OCC(CC)CCCC

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.63
CYP3A4 P08684 5/20 0.54
TDP1 Q9NUW8 2/20 0.54
ATM Q13315 2/20 0.54
ALDH1A1 P00352 6/20 0.48
CA2 P00918 4/20 0.48
RECQL P46063 1/20 0.46
LMNA P02545 3/20 0.44
MAPK1 P28482 3/20 0.44
HSD17B10 Q99714 1/20 0.43
PRSS1 P07477 1/20 0.43
PRSS2 P07478 1/20 0.43
PRSS3 P35030 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
MMP9 P14780 1/20 0.38
MMP8 P22894 1/20 0.38
MMP14 P50281 1/20 0.38
CA1 P00915 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31362015 1.00 TSHR (0.63) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL29109724 0.91 TSHR (0.60) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL28095183 0.88 TSHR (0.63) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL29558890 0.88 TSHR (0.55) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL29557819 0.88 TSHR (0.55) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL30767727 0.88 TSHR (0.50) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL4239989 0.86 TSHR (0.59) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL28825130 0.84 TSHR (0.58) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL28145709 0.84 TSHR (0.51) TSHRCYP3A4TDP1ATMALDH1A1
SCHEMBL9008203 0.83 TSHR (0.65) TSHRCYP3A4TDP1ATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 476 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12378330-B2 Process for preparing polypropylene composition BOREALIS AG (AT) 2025-08-05 US claimed
CN-117924571-A Process for preparing heterophasic propylene copolymers 北欧化工股份公司 2024-04-26 CN claimed
US-20200231795-A1 PROCESS FOR PRODUCING HETEROPHASIC COPOLYMERS OF PROPYLENE BOREALIS AG (AT) 2020-07-23 US claimed
US-20190315953-A9 PROCESS FOR PRODUCING HETEROPHASIC COPOLYMERS OF PROPYLENE BOREALIS AG (AT) 2019-10-17 US claimed
US-20180244904-A1 PROCESS FOR PRODUCING HETEROPHASIC COPOLYMERS OF PROPYLENE BOREALIS AG (AT) 2018-08-30 US claimed
EP-3259315-A1 PROCESS FOR PRODUCING HETEROPHASIC COPOLYMERS OF PROPYLENE Borealis AG (AT) 2017-12-27 EP claimed
WO-2016131907-A1 PROCESS FOR PRODUCING HETEROPHASIC COPOLYMERS OF PROPYLENE BOREALIS AG (AT) 2016-08-25 WO claimed
EP-4747289-A1 CAST FILM COMPRISING POLYPROPYLENE COMPOSITION WITH IMPROVED MECHANICAL, OPTICAL AND BARRIER PROPERTIES Borealis GmbH (AT) 2026-05-27 EP disclosed
EP-4747288-A1 PROPYLENE COMPOSITIONS WITH IMPROVED SEALING AND BARRIER PROPERTIES Borealis GmbH (AT) 2026-05-27 EP disclosed
EP-4552843-B1 MACHINE DIRECTION ORIENTED (MDO) MULTILAYER FILM BOREALIS GMBH (AT) 2026-05-20 EP disclosed
EP-4733329-A1 PREPARATION OF MAGNESIUM CHLORIDE COMPLEX FOR SIRIUS ZN CATALYST SYNTHESIS FROM WET MGCL2 Borealis GmbH (AT) 2026-04-29 EP disclosed
US-12565578-B2 Polypropylene-polyethylene blends with improved properties BOREALIS AG (AT) 2026-03-03 US disclosed
US-12534553-B2 Stiff blown film BOREALIS AG (AT) 2026-01-27 US disclosed
WO-2012007427-A1 CATALYST COMPONENT BOREALIS AG (AT) 2012-01-19 WO disclosed
WO-2012007430-A1 CATALYST COMPONENT BOREALIS AG (AT) 2012-01-19 WO disclosed
US-5250202-A Phenyalkyl glycidyl ether addition products CIBA-GEIGY CORPORATION (US) 1993-10-05 US disclosed
EP-0263069-B1 ANTI-FOAM AGENT FOR AQUEOUS SYSTEMS AND ITS USE CIBA-GEIGY AG (CH) 1993-07-28 EP disclosed
US-5097076-A PHENYLALKYL GLYCIDYL ETHER ADDITION PRODUCTS CIBA-GEIGY CORPORATION (US) 1992-03-17 US disclosed
EP-0420807-A1 Addition products of alkylene and styrene oxide on arylalkanols CIBA-GEIGY AG (CH) 1991-04-03 EP disclosed
EP-0263069-A2 Anti-foam agent for aqueous systems and its use CIBA-GEIGY AG (CH) 1988-04-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12565578-B2 Polypropylene-polyethylene blends with improved properties XPA, CRHR2, LBR TSHR 2553/4885CYP3A4 1973/4885TDP1 2922/4885
US-12534553-B2 Stiff blown film FPR2, MYH2, XRN2 TSHR 3334/4885CYP3A4 4018/4885TDP1 650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.